R. E. Ware, M. De-montalembert, L. Tshilolo, and M. R. Abboud, Sickle cell disease, Lancet, vol.390, issue.17, p.28159390, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-00696264

D. Manwani and P. S. Frenette, Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies, Blood, vol.122, issue.24, p.24052549, 2013.

D. Zhang, C. Xu, D. Manwani, and P. S. Frenette, Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology, Blood, vol.127, issue.7, p.26758915, 2016.

R. B. Francis and L. J. Haywood, Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease, J Natl Med Assoc, vol.84, issue.7, p.1629925, 1992.

E. Graido-gonzalez, J. C. Doherty, E. W. Bergreen, G. Organ, M. Telfer et al., Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis, Blood, vol.92, issue.7, p.9746797, 1998.

H. Croizat, Circulating cytokines in sickle cell patients during steady state, Br J Haematol, vol.87, issue.3, p.7527647, 1994.

A. Pathare, S. A. Kindi, S. Daar, and D. Dennison, Cytokines in sickle cell disease, Hematology, vol.8, issue.5, pp.329-366, 2003.

A. Pathare, A. Kindi, S. Alnaqdy, A. A. Daar, S. Knox-macaulay et al., Cytokine profile of sickle cell disease in Oman, Am J Hematol, vol.77, issue.4, p.15551290, 2004.

B. Keikhaei, A. R. Mohseni, R. Norouzirad, M. Alinejadi, S. Ghanbari et al., Altered levels of proinflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition, Eur Cytokine Netw, vol.24, issue.1, p.23608554, 2013.

W. Vilas-boas, V. Cerqueira, B. A. Figueiredo, C. V. Santiago, R. P. Da-guarda et al., Association of homocysteine and inflammatory-related molecules in sickle cell anemia, Hematology, vol.21, issue.2, p.26334689, 2016.

L. L. Lanier, Shades of grey-the blurring view of innate and adaptive immunity, Nat Rev Immunol, vol.13, issue.2, pp.73-77, 2013.

D. I. Godfrey, L. Nours, J. Andrews, D. M. Uldrich, A. P. Rossjohn et al., Unconventional T Cell Targets for Cancer, Immunotherapy. Immunity, vol.48, issue.3, p.29562195, 2018.

P. Vantourout and A. Hayday, Six-of-the-best: unique contributions of gammadelta T cells to immunology, Nat Rev Immunol, vol.13, issue.2, pp.88-100, 2013.

C. M. Crosby and M. Kronenberg, Tissue-specific functions of invariant natural killer T cells, Nat Rev Immunol, vol.18, issue.9, p.29967365, 2018.

S. Chandra and M. Kronenberg, Activation and Function of iNKT and MAIT Cells, Adv Immunol, vol.127, p.26073984, 2015.

M. Salou, K. Franciszkiewicz, and O. Lantz, MAIT cells in infectious diseases, Curr Opin Immunol, vol.48, p.28750261, 2017.

B. Martin, K. Hirota, D. J. Cua, B. Stockinger, and M. Veldhoen, Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals, Immunity, vol.31, issue.2, pp.321-351, 2009.

F. Trottein and C. Paget, Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections. Front Immunol, vol.9, p.30116242, 2018.

J. P. Sherlock, B. Joyce-shaikh, S. P. Turner, C. C. Chao, M. Sathe et al., IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8-entheseal resident T cells, Nat Med, vol.18, issue.7, p.22772566, 2012.

K. Venken and D. Elewaut, IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear, Curr Rheumatol Rep, vol.17, issue.5, p.30, 2015.

C. Mortier, S. Govindarajan, K. Venken, and D. Elewaut, It Takes "Guts" to Cause Joint Inflammation: Role of Innate-Like T Cells, Front Immunol, vol.9, p.30008717, 2018.

G. Lezmi, A. Taam, R. Dietrich, C. Chatenoud, L. De-blic et al., Circulating IL-17-producing mucosal-associated invariant T cells (MAIT) are associated with symptoms in children with asthma, Clin Immunol, vol.188, p.29196148, 2018.

M. L. Michel, A. C. Keller, C. Paget, M. Fujio, F. Trottein et al., Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia, J Exp Med, vol.204, issue.5, p.17470641, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00135759

P. H. Papotto, J. C. Ribot, and B. Silva-santos, IL-17(+) gammadelta T cells as kick-starters of inflammation, Nat Immunol, vol.18, issue.6, p.28518154, 2017.

K. L. Wallace, M. A. Marshall, S. I. Ramos, J. A. Lannigan, J. J. Field et al., NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines, Blood, vol.114, issue.3, pp.667-76, 2009.

G. Lin, J. J. Field, J. C. Yu, R. Ken, D. Neuberg et al., NF-kappaB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors, PLoS One, vol.8, issue.10, p.24124453, 2013.

J. J. Field, G. Lin, M. M. Okam, E. Majerus, J. Keefer et al., Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson, Blood, vol.121, issue.17, p.23377438, 2013.

L. Moreira-teixeira, M. Resende, M. Coffre, O. Devergne, J. P. Herbeuval et al., Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells, J Immunol, vol.186, issue.10, p.21478400, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00592076

M. Baron, R. Belo, D. Cathelin, L. Moreira-teixeira, C. Cartery et al., Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised, PLoS One, vol.9, issue.8, p.25144742, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01344562

O. S. Platt, Sickle cell anemia as an inflammatory disease, J Clin Invest, vol.106, issue.3, pp.337-345, 2000.

J. D. Milner, J. M. Brenchley, A. Laurence, A. F. Freeman, B. J. Hill et al., Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, Nature, vol.452, issue.7188, pp.773-779, 2008.

P. Miossec, T. Korn, and V. K. Kuchroo, Interleukin-17 and type 17 helper T cells, N Engl J Med, vol.361, issue.9, pp.888-98, 2009.

B. W. Kirkham, A. Kavanaugh, and K. Reich, Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis, Immunology, vol.141, issue.2, p.23819583, 2014.

Y. Iwakura, S. Nakae, S. Saijo, and H. Ishigame, The roles of IL-17A in inflammatory immune responses and host defense against pathogens, Immunol Rev, vol.226, pp.57-79, 2008.

S. L. Gaffen, An overview of IL-17 function and signaling, Cytokine, vol.43, issue.3, p.18701318, 2008.

L. Roussel, F. Houle, C. Chan, Y. Yao, J. Berube et al., IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation, J Immunol, vol.184, issue.8, p.20228195, 2010.

C. Konya, Z. Paz, S. A. Apostolidis, and G. C. Tsokos, Update on the role of Interleukin 17 in rheumatologic autoimmune diseases, Cytokine, vol.75, issue.2, p.26028353, 2015.

V. Li-thiao-te, F. Uettwiller, P. Quartier, F. Lacaille, B. Bader-meunier et al., Coexistent sicklecell anemia and autoimmune disease in eight children: pitfalls and challenges, Pediatr Rheumatol Online J, vol.16, issue.1, p.29343274, 2018.

I. C. Bandeira, L. B. Rocha, M. C. Barbosa, D. B. Elias, J. A. Querioz et al., Chronic inflammatory state in sickle cell anemia patients is associated with HBB(*)S haplotype, Cytokine, vol.65, issue.2, p.24290434, 2014.

B. O. Musa, G. C. Onyemelukwe, J. O. Hambolu, A. I. Mamman, and A. H. Isa, Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis, Clin Vaccine Immunol, vol.17, issue.4, pp.602-610, 2010.

M. H. Qari, U. Dier, and S. A. Mousa, Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease, Clin Appl Thromb Hemost, vol.18, issue.2, pp.195-200, 2012.

G. Parlakgul, E. Guney, B. Erer, Z. Kilicaslan, H. Direskeneli et al., Expression of regulatory receptors on gammadelta T cells and their cytokine production in Behcet's disease, Arthritis Res Ther, vol.15, issue.1, 2013.

R. S. Nickel, I. Osunkwo, A. Garrett, J. Robertson, D. R. Archer et al., Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy, Br J Haematol, vol.169, issue.4, p.25753210, 2015.

T. S. Hinks, X. Zhou, K. J. Staples, B. D. Dimitrov, A. Manta et al., Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms, J Allergy Clin Immunol, vol.136, issue.2, p.25746968, 2015.

E. Mamessier, A. Nieves, A. M. Lorec, P. Dupuy, D. Pinot et al., T-cell activation during exacerbations: a longitudinal study in refractory asthma, Allergy, vol.63, issue.9, p.18699937, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01765662